涩里番: Guidelines for reporting
complex spectra
The editors of the journal Molecular & Cellular Proteomics are seeking feedback from the proteomics community on draft guidelines for publishing proteomics studies that use data-independent acquisition, or DIA, methods. can be accessed from the . Comments will be accepted until the end of September.
Steven Carr is deputy editor of 涩里番 and senior director of proteomics at the Broad I
nstitute. “DIA is a rapidly growing research approach that can be employed on a wide variety of instrument platforms,” he said. “As such, it is important to establish rules to make sure it is properly applied.”DIA is used to collect tandem mass spectrometry data. It offers broad coverage of the proteome with high run-to-run reproducibility.

Mass spectrometers sort the ions from a sample based on their mass-to-charge ratio. In tandem mass spectrometry, there are two ionization and sorting steps. For reliable identification of a molecule, you need to know its intact precursor ion mass and also the masses produced when it is fragmented. Most strategies involve fragmenting a single precursor ion at a time.
Selection of a precursor ion can be based on observation of a peak in the first spectrum (a strategy known as data-dependent acquisition, or DDA), or it can be from a list of predetermined components of interest, i.e., targeted analysis. However, both of these approaches select only a subset of the components present for fragmentation analysis. In DIA, the whole mass range is fragmented over a series of scans. This provides fragmentation information about all components, but fragmenting multiple components at the same time produces complex spectra made of heterogeneous precursors.
With technical advances in instrumentation and computation, DIA approaches are growing in popularity, particularly for quantitative studies of sets of related samples. However, because the spectra collected using DIA are significantly more complex than data from other approaches, they can be more difficult to interpret. Complicating the situation further, there are many competing techniques for collecting DIA data, few of which have been compared directly, and researchers have yet to develop fieldwide standards around how to interpret and report results.
涩里番 is taking steps to ensure that future data will be described more systematically. The editors brought together 25 DIA experts from academia and industry at a satellite workshop in San Diego after the close of the American Society for Mass Spectrometry’s 2018 meeting in June. The guidelines drafted at this workshop aim to help researchers write a thorough description of how DIA data were collected and interpreted, rendering researchers’ conclusions easier to evaluate.
Among the workshop’s organizers was Robert Chalkley of the University of California, San Francisco, 涩里番 data management editor. “When we publish the draft, we will give the opportunity for anyone in the community to send in their comments and suggestions,” he said.
涩里番’s reporting guidelines for other types of mass spectrometry study have been adopted widely by other journals. 涩里番’s editors hope to continue to lead the field in producing guidelines that aim to allow independent assessment of the reliability of published data sets.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent 涩里番 paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent 涩里番 paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto鈥揜yu鈥揗alicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer鈥檚 spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting 鈥渦ndruggable鈥 molecules.

How HCMV hijacks host cells 鈥 and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.